Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland

JOURNAL ARTICLE published September 2013 in Journal of Medical Economics

Authors: Thomas R. Einarson | Hanna Pudas | Roman Zilbershtein | Rasmus Jensen | Colin Vicente | Charles Piwko | Michiel E. H. Hemels

Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)

JOURNAL ARTICLE published 1 January 2021 in Journal of Medical Economics

Authors: Mohd Rozaini Rosli | David Bin-Chia Wu | Chin Fen Neoh | Mahmathi Karuppannan

Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada

JOURNAL ARTICLE published 16 November 2021 in Journal of Medical Economics

Authors: Guanmin Chen | Behnam Sharif | Brittany Gerber | Megan S. Farris | Tara Cowling | Czerysh Cabalteja | Jennifer W. Wu | Bridget Maturi | Kristoph Klein-Panneton

Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study

JOURNAL ARTICLE published 1 November 2020 in Journal of Medical Economics

Authors: Marissa J. Carter

The economic burden of spinal muscular atrophy

JOURNAL ARTICLE published 2 August 2016 in Journal of Medical Economics

Authors: Edward P. Armstrong | Daniel C. Malone | Wei-Shi Yeh | Georg J. Dahl | Rees L. Lee | Nicholas Sicignano

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada

JOURNAL ARTICLE published February 2013 in Journal of Medical Economics

Authors: Martine Pettigrew | Kirsten Garces | Robert Deuson | Jeannine Kassis | Vincent Laroche

A real-world assessment of healthcare costs associated with agitation in Alzheimer’s dementia

JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics

Authors: George Grossberg | Annette Urganus | Jeff Schein | Rebecca Bungay | Martin Cloutier | Marjolaine Gauthier-Loiselle | Deborah Chan | Annie Guerin | Jyoti Aggarwal

Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: J Jaime Caro | Ipek Ozer Stillman | Aurelie Danel | Denis Getsios | Phillip McEwan

Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Manjiri D. Pawaskar | Amy L. Blickensderfer | Byron J. Hoogwerf | Ralph Quimbo | Rolin Wade

Clinical outcome of hypertension management

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: Vivian WY Lee | Tony HW Chan | Tina TL Ko | Kenneth KC Lee | Brian Tomlinson

Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico

JOURNAL ARTICLE published 1 December 2016 in Journal of Medical Economics

Authors: Namita Tundia | Paulo Gustavo Kotze | Jorge Rojas Serrano | Mirhelen Mendes de Abreu | Martha Skup | Dendy Macaulay | James Signorovitch | Leonardo Chaves | Jingdong Chao | Yanjun Bao

Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Michael S. Broder | Eunice Y. Chang | Tanya G.K. Bentley | Timothy Juday | Jonathan Uy

Improved hospital discharge and cost savings with esophageal cooling during left atrial ablation

JOURNAL ARTICLE published 31 December 2023 in Journal of Medical Economics

Authors: Christopher Joseph | Julie Cooper | Rishi Sikka | Jason Zagrodzky | Robert W. Turer | Samuel A. McDonald | Erik Kulstad | James Daniels

Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis

JOURNAL ARTICLE published 2 July 2016 in Journal of Medical Economics

Authors: W. Weng | Y. Liang | E. S. Kimball | T. Hobbs | S. Kong | B. Sakurada | J. Bouchard

Estimated cost savings associated with the use of valsartan in heart failure in a large US health plan

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Dean G Smith | Feride Frech-Tamas | William Randle | Ronald Preblick

Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data

JOURNAL ARTICLE published 4 March 2018 in Journal of Medical Economics

Authors: Joseph A. Sierra | Mona Shah | Max S. Gill | Zachery Flores | Hiten Chawla | Francine R. Kaufman | Robert Vigersky

Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US

JOURNAL ARTICLE published 3 May 2016 in Journal of Medical Economics

Authors: J. Mark Stephens | Xiaoyan Li | Maureen Reiner | Spiros Tzivelekis

Updated trends in US brand-name and generic drug competition

JOURNAL ARTICLE published 1 September 2016 in Journal of Medical Economics

Research funded by Pharmaceutical Research and Manufacturers of America Foundation (N/A (see 3rd party support disclosure))

Authors: Henry Grabowski | Genia Long | Richard Mortimer | Ani Boyo

Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise

JOURNAL ARTICLE published January 2012 in Journal of Medical Economics

Authors: Gerhart Knerer | Afisi Ismaila | David Pearce

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Yonghua Jing | Stephen S. Johnston | Robert Fowler | John A. Bates | Robert A. Forbes | Tony Hebden